Dendritic cell/multiple myeloma (MM) fusion vaccine with lenalidomide maintenance after autologous hematopoietic cell transplant (HCT) induces MM-specific immunity, BMT CTN 1401 Meeting Abstract
| Authors: | Chung, D. J.; Shah, N.; Stroopinsky, D.; Wu, J.; Bisharat, L.; Callander, N. S.; Logan, B.; Anderson, K. C.; Dhakal, B; Devine, S. M.; Efebera, Y.; Geller, N.; Hematti, P.; Holmberg, L. A.; Howard, A.; Johnson, B. D.; Lazarus, H. M.; Malek, E.; McCarthy, P.L.; McKenna, D. H.; Mendizabal, A.; Munshi, N. C.; O’Donnell, L. C.; Rapoport, A. P.; Nooka, A.; Reese, J. S.; Soiffer, R. J.; Uhl, L.; Cheloni, G.; Karagkouni, D.; Vlachos, I.; Young, J.; Rosenblatt, J.; Waller, E. K.; Pasquini, M. C.; Avigan, D. E. |
| Abstract Title: | Dendritic cell/multiple myeloma (MM) fusion vaccine with lenalidomide maintenance after autologous hematopoietic cell transplant (HCT) induces MM-specific immunity, BMT CTN 1401 |
| Meeting Title: | 2022 Tandem Meetings of ASTCT and CIBMTR |
| Journal Title: | Transplantation and Cellular Therapy |
| Volume: | 28 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2022 Apr 23-26 |
| Meeting Location: | Salt Lake City, UT |
| ISSN: | 2666-6375 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-03-01 |
| Start Page: | S223 |
| End Page: | S224 |
| DOI: | 10.1016/S2666-6367(22)00443-2 |
| PROVIDER: | manual |
| Notes: | Meeting Abstract: 282 -- Located within the section named "Poster Session - Cellular And Gene Therapy - Clinical, Processing" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work